YA
Yarrow Bioscience Inc
YARW · NASDAQ
$28.68 -0.45% (-$0.13)
1M -28.35%
Market Cap $493.2K
P/E Ratio -
Div. Yield 1.40%
ROE 70.23%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.02x
P/S 1.02x
PEG N/A
Growth
40 /100
Stable Book val. growth 3.82%
Rev. growth 6.12%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 3,513.07%
Op. margin 4,134.65%
Gross margin 564.94%
Quality
0 /100
Poor Asset turnover 0.02x
ROA 79.26%
ROIC 90.35%
Debt
100 /100
Low Current ratio 15.26x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
47 /100
Moderate Profitable years 0
EPS volatility 21.15%
Beta 2.07x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o YARW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rebecca Velez Frey
Employees
10
Headquarters
New Haven
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report